Gap Fund

Gap Fund 2023 Awards 

The Office of Technology Commercialization and the Office of Advancement are pleased to announce the 2023 Gap Fund awards recipients. The funds are designed to support innovative research projects with high commercial potential that bridge the gap between cutting-edge research and real-world applications, address important scientific challenges, and pave the way for significant advancements in the field. We extend our heartfelt congratulations to the following recipients: 

Dr. Radoslav Goldman 
Project Title: Non-invasive Serologic Detection of Liver Fibrosis
Departments: Oncology; Biochemistry and Molecular & Cellular Biology 

Dr. Tinatin Brelidze and Dr. Yuichiro Suzuki 
Project Title: Use of Kv11.1 Channel Inhibitors for Treatment of Pulmonary Hypertension 
Department: Pharmacology & Physiology 

Dr. Kai Liu 
Project Title: Nanoporous Foam Based Multifunctional Filters Against Multi-hazards  
Department: Physics 

These projects were selected after a rigorous review process by our esteemed panel of experts. Each proposal demonstrated significant potential for advancing cutting-edge research and translating it into practical applications with tangible impact. The chosen projects span a wide range of disciplines and showcase the exceptional talent and diversity of our researchers. We are confident that the recipients’ pioneering work will bring about meaningful advances in their respective fields.  

We would like to express our sincere gratitude to the faculty members who submitted their proposals and our dedicated reviewers who ensured a fair and thorough evaluation process. We also extend our appreciation to our generous donors, Bill Baker (C’54, Parent ’80, ’84, ’88) and Ruth Baker (Parent ’80, ’84, and ’88), whose gift has made these awards possible. 

Full Proposal Applications for the Third Round of Georgetown Gap Funding

Applicants invited to submit a full proposal application, please complete and submit this APPLICATION FORM no later than 5 pm EST, Monday, May 22, 2023.

WORKSHOP REMINDER: All applicants who will submit a full proposal application must attend the virtual Full Application Gap Fund Workshop at 10 am EST, Friday, May 5, 2023. Please note that the Zoom link to join the workshop will be sent by email.

Letters of Intent for the Third Round of Georgetown Gap Funding

Georgetown’s Office of Technology Commercialization (OTC), in collaboration with the Office of Advancement and with input from Georgetown’s Leadership, is launching the Third round of Gap Funding to advance promising biomedical technologies to the next value inflection point. OTC is seeking solicitation for Letters of Intent (LOI), beginning March 24, 2023. The deadline for LOI submission is April 12, 2023. The grant will be in the range of $100,000 per project for a year.  To be eligible for this funding, technology must have been disclosed to OTC, which has secured patent protection. Funded projects may be eligible for additional support in subsequent years, subject to the future availability of funds and depending on performance relative to identified milestones.

The Gap Fund was established last year with a $1M gift from Georgetown alumnus Bill Baker (C’54, Parent’ 80, ‘84, ‘83) and his wife Ruth Baker. In today’s federal budgetary environment, there is a particularly acute challenge to getting earlier-stage and bench science “off the ground,” and many early-stage discoveries fail to realize their potential for impact due to a lack of funding after initial proof of concept. These research projects languish in the funding gap often called the “valley of death.” Georgetown’s Gap Fund is intended to overcome some of the funding barriers and to strengthen the impact on innovation from our research enterprise. It is hoped that funded projects will be more likely to be translated into new products or services for public benefit.

To learn more about the Gap Fund, please visit the following link.

Award Opportunity

The development milestone-driven Gap Fund award provides up to $100,000 for each biomedical technology for one year with an opportunity to qualify for subsequent funding.

Eligibility Criteria

  • The technology has some proof of concept data and addresses unmet medical needs.
  • The technology has been formally disclosed to OTC, and a pending application or patent has been issued.
  • The technology was found to need additional proof of concept or validation.
  • The technology is not currently licensed or optioned.
  • The technology has not been previously funded through the Gap Fund program in prior years.
  • Incremental additional funding could help the technology reach a milestone that would provide distinct additional value to the technology.
  • The applicant has shown commitment to follow through on the research.


  • Submit your Letters of Intent (1-2 pages) to OTC.
  • These LOIs will be reviewed and scored by the Gap Fund Advisory Board.
  • A select group of applicants will be invited to submit a Full Application (3-5 pages). 
  • The Gap Fund Advisory Board will review and score the full application.
  • Two virtual workshops will be held for applicants to provide additional background on the fund and guidance for the application process. 
  • Late submissions will not be accepted for any reason.  Proposals received after the deadline will not be reviewed.
Gap Fund TimelineDate
Solicitation for Letters of Intent (LOI) March 24, 2023
Gap Fund LOI WorkshopMarch 31, 2023
LOI Submission DeadlineApril 12, 2023
Notification to those Selected for Full ApplicationApril 27, 2023
Full Application Gap Fund Workshop (required for Selected Applicants)May 5, 2023
Full Proposal Deadline Submission for those SelectedMay 22, 2023
Announce AwardeesJune 15, 2023